1-n-(halo-3-pyridylmethyl)-n-methylamino-1-alkylamino-2- nitroethylene derivatives for controlling fleas in domestic animals
CA 2113908 C · Owner: Novartis Ag · Inventors: Gsell, Laurenz; Maienfisch, Peter; Friedel, Thomas
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The compounds of formula I are described wherein, Hal is halogen, such as fluorine chlorine, bromine or iodine;, R1 is hydrogen C1-C6alkyl or C3-C7cycloalkyl;, R2 is hydrogen C1-C6alkyl or C3-C7cycloalkyl, and, R3 is hydrogen or C1-C6alkyl for use in a method of controlling fleas in domestic animals especially in , dogs and cats, wherein systemic administration is preferred. The compounds of formula I are adminis-, tered in an amount effective against fleas via the digestive tract or via the blood of the host, animal and thus systemically to the domestic animal especially the dog or the , cat.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 23, 1992 and granted March 25, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 23, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 23, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.